Zai Lab Limited - ADR
ZLAB
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.68B
Close$
$-37.97
258% downside
Current Fair Value
258% downsideOvervalued by 258% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.68 Billion |
|---|---|
| Enterprise Value | $2.36 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.6 |
| Beta | 0.83 |
| Outstanding Shares | 111,697,338 |
Return
| Return on Equity | -31.01% |
|---|---|
| Return on Assets | -17.51% |
| Return on Invested Capital | -34.11% |
Valuation & Multiples
| P/E Ratio | -13.01 |
|---|---|
| PEG | -52.46 |
| Price to Sales | 6.01 |
| Price to Book Ratio | 4.81 |
| Enterprise Value to Revenue | 5.25 |
| Enterprise Value to EBIT | -10.7 |
| Enterprise Value to Net Income | -13 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | 0.46 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$-0.68
Average shareholder expectationRevenue Estimate
$103.87 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.56
Average shareholder expectationRevenue Estimate
$108.83 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 2738.39% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | 363,400▲ 18.49% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 38.59%▲ 13.08% |
|---|---|
| Total Invested | $819.03M▲ 54.26% |
| Investors Holding | 97▼ 8.00% |
ESG Score
No data
About Zai Lab Limited
1,784 employees
CEO: Ying Du Zai Lab Limited, established in 2013 and based in Shanghai, China, is a biopharmaceutical company dedicated to developing and bringing to market innovative medical treatments. Its core focus spans oncology, autoimmune diseases, infectiou...